Neutrophil-lymphocyte ratio and carotid plaque burden in patients with essential thrombocythemia and polycythemia vera

Nutr Metab Cardiovasc Dis. 2022 Aug;32(8):1913-1916. doi: 10.1016/j.numecd.2022.04.013. Epub 2022 Apr 22.

Abstract

Background and aims: Chronic inflammation plays a critical role in the pathogenesis of myeloproliferative neoplasm (MPN), and inflammatory conditions are closely related to the development and exacerbation of atherosclerosis. This study aimed to compare carotid plaque burden and neutrophil-lymphocyte ratio (NLR) in the essential thrombocythemia (ET)/polycythemia vera (PV) and control groups.

Methods and results: We retrospectively assessed carotid plaque burden and NLR in patients with ET/PV between January 2010 and September 2021 and propensity-score matched these patients to control subjects from the general population. All patients underwent carotid imaging using carotid ultrasonography for atherosclerosis screening. After 3:1 propensity-score matching, 140 patients in the control group were matched to 51 patients in ET/PV group. The mean NLR was significantly higher in the MPN group than in the control group (4.77 ± 3.96 vs. 1.93 ± 1.03, p < 0.001). The carotid plaque score was also higher in MPN group than in the control group (2.37 ± 1.47 vs. 1.94 ± 1.17, p = 0.038).

Conclusion: Patients with PV/ET show a higher NLR and carotid plaque burden than the normal population. This reflected that PV/ET was a highly inflammatory and atherosclerotic condition expressing potentially increased cardiovascular risk.

Keywords: Carotid plaque burden; Essential thrombocythemia; Neutrophil–lymphocyte ratio; Polycythemia vera.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Atherosclerosis*
  • Humans
  • Lymphocytes / pathology
  • Myeloproliferative Disorders* / complications
  • Myeloproliferative Disorders* / epidemiology
  • Neutrophils / pathology
  • Polycythemia Vera* / diagnosis
  • Polycythemia Vera* / etiology
  • Polycythemia Vera* / pathology
  • Retrospective Studies
  • Thrombocythemia, Essential* / complications
  • Thrombocythemia, Essential* / diagnosis
  • Thrombocythemia, Essential* / epidemiology